Brain radiotherapy added to first-line immunochemotherapy improves survival in patients with treatment-naïve, driver-negative lung adenocarcinoma and synchronous brain metastases

ObjectiveThe optimal integration of brain radiotherapy with first-line immunochemotherapy for treatment-naïve, driver-negative lung adenocarcinoma patients with synchronous brain metastases remains unclear. This study assessed the efficacy and safety of this combined strategy.MethodologyIn this retr...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Rui Wang, Jianxi Zhou, Li Xiao, Hongling Lu, Yaru Kong, Yongchao Yu, Yunchuan Sun, Jiaju Zhang, Yingnan Zhou
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-03-01
Sarja:	Frontiers in Oncology
Aiheet:	brain metastases immunotherapy intracranial progression-free survival non-small cell lung cancer overall survival radiotherapy
Linkit:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1808429/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!